Induction chemoradiotherapy with cisplatin plus vinorelbine and irradiation, followed by surgery in cT1-3N2M0, stage IIIA non-small cell lung cancer.
Phase 2
Recruiting
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000005416
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
Synchronous / metachronous double cancer without in-situ carcinoma. History of chest irradiation Current severe infection Severe cardiac and/or pulmonary diseases Severe diabetes merritus Steroid users Female in pregnancy Patients who is evaluated as "not suitable" for clinical trial by practitioners
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method 3-yr recurrent-free survival, efficacy, percentage of accomplish surgical resection, percentage of adverse effects and severe adverse effects of the treatment